Related references
Note: Only part of the references are listed.
Article
Chemistry, Multidisciplinary
Alvaro Mallagaray et al.
Summary: Nuclear Magnetic Resonance (NMR) spectra of human serum and plasma can identify the signals GlycA and GlycB, which come from the acetyl groups of glycoprotein glycans and serve as markers for inflammatory processes. This study provides a detailed assignment of glycoprotein glycan NMR signals in human serum, revealing that GlycA and GlycB signals correspond to specific N-glycans. The concentrations of acute phase glycoproteins, determined conventionally, show a strong correlation with distinctive features in the NMR spectra, enabling the simultaneous quantification of multiple acute phase inflammation proteins.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
(2023)
Article
Biochemistry & Molecular Biology
Hao Wang et al.
Summary: Increasing the localization of ACE2 near endocytic lipids enhances viral infectivity, shedding light on the selective severity of COVID-19 in aged and diseased populations.
JOURNAL OF BIOLOGICAL CHEMISTRY
(2023)
Article
Biochemistry & Molecular Biology
Larisa I. Labzin et al.
Summary: Macrophages are important cells in the development of COVID-19, and ACE2 receptors are only present on a subset of macrophages at infection sites. Research shows that ACE2-deficient macrophages do not replicate the virus or induce inflammatory cytokine expression, while ACE2-overexpressing macrophages can replicate and release the virus.
Review
Pharmacology & Pharmacy
Alankrita Rani et al.
Summary: High-density lipoproteins (HDL) are complex nanoparticles involved in important metabolic and vascular functions. Dysregulation of HDL can lead to inflammatory remodeling and dysfunction. Monocytes and macrophages play a critical role in vascular inflammation. HDL-based nanotherapeutics show potential in treating vascular diseases by targeting these cells.
Article
Peripheral Vascular Disease
Sandra Parra et al.
Summary: This study found that the lipid profile of COVID-19 patients at admission can serve as a prognostic biomarker, with hypolipidemia including HDL levels being associated with a higher risk of death and worse clinical manifestations.
ATHEROSCLEROSIS PLUS
(2023)
Article
Chemistry, Analytical
Philipp Nitschke et al.
Summary: This study presents a J-Edited Diffusional (JEDI) proton NMR spectroscopic approach that selectively enhances signals from inflammatory markers in blood serum. The results show that JEDI is an improved method for selectively investigating inflammatory signals in serum and may have widespread diagnostic applicability to disease states associated with systemic inflammation.
ANALYTICAL CHEMISTRY
(2022)
Article
Peripheral Vascular Disease
Sidar S. Aydin et al.
Summary: This study aimed to investigate the relationship between lipid levels and mortality in COVID-19 patients. It found that low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) levels were significantly associated with COVID-19-related death risk. Low and high LDL-C, low HDL-C, and high TG levels were negatively correlated with mortality in COVID-19 patients.
Article
Genetics & Heredity
Mojgan Masoodi et al.
Summary: This study found significant differences in plasma metabolic signatures between COVID-19 patients and control group, primarily in lipid and amino acid metabolism. Protein systems biology analysis revealed that COVID-19 mainly impacted sphingolipid, tryptophan, tyrosine, glutamine, arginine, and arachidonic acid metabolism pathways. Additionally, decreased levels of GABA could serve as a potential biomarker and therapeutic target for COVID-19 patients.
JOURNAL OF MOLECULAR MEDICINE-JMM
(2022)
Article
Cardiac & Cardiovascular Systems
Scott T. Chiesa et al.
Summary: GlycA is associated with the development of cardiovascular disease risk and predicts the risk of hypertension and metabolic syndrome. In contrast, CRP has little correlation.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2022)
Article
Medicine, General & Internal
Fei Peng et al.
Summary: The study suggests that the TG/HDL-c ratio might be a predictive marker for mortality in COVID-19 patients. Compared to survivors, non-survivors had higher levels of white blood cells, neutrophils, C-reactive proteins, and TG/HDL-c ratio. The TG/HDL-c ratio was positively correlated with white blood cells, neutrophils, and C-reactive proteins, and patients with high TG/HDL-c ratio had worse survival.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE
(2022)
Article
Chemistry, Analytical
Reika Masuda et al.
Summary: SARS-CoV-2 infection leads to a decrease in lipoprotein-bound serum phospholipids, resulting in supra-molecular phospholipid composite (SPC) signals detected in diffusion and relaxation edited H-1 NMR spectra. This study utilized Statistical HeterospectroscoY in n-dimensions (SHYn) approach to identify the major phospholipid components contributing to the SPC signals and correlated them with lipoprotein and lipid measurements. The SPC3/SPC2 ratio was strongly correlated with the apolipoprotein B100/A1 ratio, indicating the potential of serum SPC measurement as a metric of cardiovascular risk based on a single NMR experiment.
ANALYTICAL CHEMISTRY
(2022)
Article
Endocrinology & Metabolism
Helena Castane et al.
Summary: The study found that COVID-19 infection shares many lipid alterations with other infectious/inflammatory diseases, but there are also some differences. The most notable alterations were observed in oxylipins in COVID-19 patients, while bile acids and glycerophospholipids best distinguished between COVID-19-positive and COVID-19-negative patients.
METABOLISM-CLINICAL AND EXPERIMENTAL
(2022)
Article
Microbiology
Tie Zhao et al.
Summary: COVID-19 patients may exhibit dyslipidemia, with lower levels of TC and HDL-C compared to healthy individuals. Differential proteins associated with COVID-19 are involved in lipid pathways, and SARS-CoV-2 infection may induce metabolic reprogramming.
FRONTIERS IN MICROBIOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Sebastien Tanaka et al.
Summary: This study investigated the use of recombinant HDL particles in a severe COVID-19 patient. The results showed that recombinant HDL increased ApoA1 abundance, increased the proportion of large HDL particles, and decreased the abundance of inflammatory proteins. Levels of inflammatory markers and cytokines also decreased during recombinant HDL infusion. Therefore, recombinant HDL infusion may be a potential therapeutic strategy for COVID-19 patients.
Review
Cardiac & Cardiovascular Systems
Vignesh Chidambaram et al.
Summary: Low lipid levels are associated with disease severity and mortality in COVID-19 patients.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Review
Infectious Diseases
Abbas F. Almulla et al.
Summary: This study found increased activity of the IDO enzyme in COVID-19 and severe/critical patients, suggesting that the TRYCAT pathway is involved in the pathophysiology and progression of COVID-19.
BMC INFECTIOUS DISEASES
(2022)
Article
Biochemistry & Molecular Biology
Titus Roessler et al.
Summary: By analyzing the clinical samples of a large outpatient cohort using nuclear magnetic resonance spectroscopy, we characterized COVID-19 and found markers of oxidative stress and severe dysregulation of energy metabolism. NMR markers showed predictive power comparable to laboratory parameters, and we demonstrated the interaction between metabolism and the immune system.
Article
Medicine, General & Internal
Vignesh Chidambaram et al.
Summary: This study found that individuals with higher antecedent serum high-density lipoprotein cholesterol (HDL-C) levels had a lower risk of SARS-CoV-2 infection. However, low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and triglyceride (TG) levels were not independently associated with infection risk. In COVID-19 patients, serum HDL-C and LDL-C levels transiently decreased at the time of infection.
Article
Virology
Minu Nain et al.
Summary: This study found that patients with COVID-19 have significantly low levels of high-density lipoprotein (HDL), while total cholesterol (TC) and low-density lipoproteins (LDL) levels are normal. This suggests that HDL may play an important role in COVID-19 infection and outcomes, and further research on this relationship is needed.
Article
Pharmacology & Pharmacy
Wenyu Chen et al.
Summary: This study utilized untargeted metabolomics analysis to characterize the metabolic alterations in COVID-19 patients with nucleic acid turning negative. The results showed dysregulation in amino acid metabolism and lipid metabolism, highlighting the need for specific post-treatment care to aid the recovery of COVID-19 patients.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Pharmacology & Pharmacy
Stanislas Faguer et al.
Summary: Viral infections can cause cytokine storms and multiorgan failure in individuals with immunosuppression or specific genetic background. This study examined the use of an ApoA-I-containing HDL mimetic in four severe COVID-19 patients with cytokine storms. The treatment resulted in early clinical improvement in three patients and provides initial safety and proof-of-concept data for further evaluation.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Julia T. Stadler et al.
Summary: This study evaluates the impact of COVID-19 infection on HDL function and metabolism, and finds that low HDL cholesterol efflux capacity is associated with increased mortality risk in COVID-19 patients, independent of HDL-cholesterol levels.
Article
Immunology
Laura E. Martinez-Gomez et al.
Summary: This study aimed to characterize the profile of amino acids and acylcarnitines in COVID-19 patients. The findings suggest that metabolic imbalance may affect disease progression in COVID-19 patients, and phenylalanine may serve as a potential metabolic biomarker for evaluating disease severity.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Multidisciplinary Sciences
Atish Gheware et al.
Summary: This study found significantly higher ACE2 protein expression in the lung tissues of deceased COVID-19 patients, which correlated with pathological changes and disease severity.
SCIENTIFIC REPORTS
(2022)
Review
Medicine, Research & Experimental
Tianshi Wang et al.
Summary: SARS-CoV-2 infection causes dysregulation of host cell metabolism and interactions between viral proteins and metabolic regulators. Cholesterol, lipid, and glucose metabolism play important roles in viral lifecycle. Understanding COVID-19 metabolism could lead to new therapeutic targets and accelerate drug repurposing or screening.
Review
Medicine, General & Internal
Christian Zanza et al.
Summary: Cytokine storm is an excessive inflammatory state caused by an immune system dysregulation, which can lead to multi-organ failure and death. Initially described in graft-versus-host disease, it has been extended to other diseases such as COVID-19. Various drugs have been tested to mitigate cytokine storm, with some showing effectiveness in reducing mortality, especially in critically ill patients.
MEDICINA-LITHUANIA
(2022)
Review
Virology
Biying Hu et al.
Summary: COVID-19, caused by SARS-CoV-2, has become a global pandemic since its emergence in Wuhan, China, in December 2019, posing a serious threat to public health. Close contact and respiratory droplets are the main modes of transmission. The cytokine storm is closely associated with disease severity and mortality, emphasizing the importance of studying and treating the cytokine storm in COVID-19.
JOURNAL OF MEDICAL VIROLOGY
(2021)
Review
Nutrition & Dietetics
Roshan Kumar Mahat et al.
Summary: This study conducted a systematic review and meta-analysis of 19 studies to evaluate the association of lipid profile with severity and mortality in COVID-19 patients. The findings suggest that levels of total cholesterol, HDL-C, and LDL-C are significantly decreased in severe cases, and HDL-C and LDL-C are lower in non-survivors compared to survivors. The lipid profile may be used for assessing the severity and prognosis of COVID-19.
CLINICAL NUTRITION ESPEN
(2021)
Article
Immunology
Rafael Luis Luporini et al.
Summary: The study found that serum phenylalanine levels are positively correlated with disease severity in COVID-19 patients, independent of inflammatory cytokines. Patients with mild disease have lower serum phenylalanine levels in the early stages of the disease.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Tao Shen et al.
Summary: Plenty of research has shown significant changes in metabolism due to COVID-19, leading to the perspective that COVID-19 is a metabolic disease. Reprogramming of amino acid, glucose, cholesterol and fatty acid is a distinctive characteristic of COVID-19 infection, offering new insights into COVID-19 pathophysiology. This metabolic reprogramming provides opportunities for developing novel biomarkers and therapeutic agents for effective adjuvant therapies against COVID-19 infection.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Multidisciplinary Sciences
Floran Begue et al.
Summary: The study showed significant changes in HDL proteome and decreased functionality in severe COVID-19 patients.
SCIENTIFIC REPORTS
(2021)
Article
Pharmacology & Pharmacy
Douglas Ricardo Souza Junior et al.
Summary: The study found significant changes in the HDL proteome of COVID-19 patients, which were associated with disease severity. Certain specific HDL proteins were related to worsening condition in hospitalized patients, while others may be associated with the survival rate of COVID-19 patients.
JOURNAL OF CLINICAL LIPIDOLOGY
(2021)
Article
Chemistry, Analytical
Samantha Lodge et al.
Summary: Nuclear magnetic resonance spectroscopy-based plasma phenotyping using DIRE technique successfully revealed diagnostic molecular signatures of SARS-CoV-2 infection in plasma. Comparison of plasma samples from different groups showed differences in concentrations of specific metabolites in SARS-CoV-2 positive patients, suggesting potential molecular markers for COVID-19 diagnosis.
ANALYTICAL CHEMISTRY
(2021)
Article
Biochemistry & Molecular Biology
James R. Hilser et al.
Summary: Individuals with features of metabolic syndrome are more susceptible to severe COVID-19 caused by SARS-CoV-2. Higher levels of serum HDL-cholesterol and apolipoprotein A1 may reduce the risk of SARS-CoV-2 infection, but genetically elevated HDL-cholesterol levels are not associated with SARS-CoV-2 infection.
JOURNAL OF LIPID RESEARCH
(2021)
Article
Multidisciplinary Sciences
Michele Dei Cas et al.
Summary: The serum lipidome of COVID-19 patients shows significant and unique dyslipidemia related to factors such as inflammation, hypoxia, coagulation state, kidney function, and age, indicating reduced defense against oxidative stress. A particular lipidome signature was identified in patients with different outcomes after 7 days, with an increase in specific lipid species like ceramides and sulfatides, potentially serving as biomarkers for disease progression and severity.
SCIENTIFIC REPORTS
(2021)
Article
Immunology
Hui Jin et al.
Summary: The study found that baseline dyslipidemia may be associated with an increased risk of re-positive or in-hospital death in COVID-19 patients, and lipid levels also change throughout the course of the disease. Additionally, there is a relationship between inflammatory biomarkers, organ function indicators, and lipid levels in patients.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Harald Mangge et al.
Summary: Kynurenine is a promising blood biomarker for predicting mortality risk in severe COVID-19 cases, with KYN levels at the time of SARS-CoV-2 diagnosis serving as an early indicator of poor outcomes. Age, KYN, ferritin, and other markers were found to significantly impact survival time, underscoring the potential of Kynurenine as a prognostic tool in COVID-19 management.
Article
Biochemistry & Molecular Biology
Franziska Schmelter et al.
Summary: The metabolic serum profile of COVID-19 patients differs significantly from healthy controls and patients with cardiogenic shock. However, individuals with anti-SARS-CoV-2 antibodies but without severe disease do not show significant metabolic disturbances. This suggests that dyslipidemia may be a confounding risk factor for COVID-19 and could be used for patient stratification.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2021)
Review
Rheumatology
Manuel Ramos-Casals et al.
Summary: Immune-related disorders in patients with COVID-19 present with diverse manifestations mimicking various inflammatory and autoimmune diseases, with clinical phenotype influenced by factors like age, sex, and ethnicity. The severity of symptoms varies greatly, from benign to life-threatening, and the pathogenesis and optimal therapy for these manifestations require further research.
NATURE REVIEWS RHEUMATOLOGY
(2021)
Article
Multidisciplinary Sciences
Lluis Masana et al.
Summary: The presence of atherogenic dyslipidaemia during COVID-19 infection is strongly associated with a worse prognosis. Low HDL cholesterol and high triglyceride concentrations, either before or during hospitalization, are strong predictors of a severe course of the disease. Lipid profiles can be considered as sensitive markers of inflammation in patients with COVID-19 and should be measured.
SCIENTIFIC REPORTS
(2021)
Review
Biochemical Research Methods
Benjamin J. Blaise et al.
Summary: Metabolic phenotyping plays a crucial role in translational biomedical research, utilizing advanced analytical technologies such as MS and NMR spectroscopy. This paper proposes an efficient protocol for statistical analysis of metabolic data generated by these methods, offering solutions for various steps in the data analytics workflow. The protocol describes a minimal set of analyses needed to rigorously investigate typical datasets encountered in metabolic phenotyping.
Article
Biochemistry & Molecular Biology
Zhiqiang Pang et al.
Summary: MetaboAnalyst version 5.0 has been introduced to facilitate comprehensive metabolomics data analysis and interpretation, with the aim of narrowing the gap from raw data to functional insights. Three new modules have been developed to assist in this goal, along with various other new functions and improvements in interface, graphics, and codebase. Users can now easily switch between compatible modules for a streamlined data analysis experience.
NUCLEIC ACIDS RESEARCH
(2021)
Review
Virology
Yanli Liu et al.
Summary: This study analyzed the potential association of dyslipidemia with the severity and mortality of COVID-19. The results showed that dyslipidemia is associated with increased severity and mortality of COVID-19. It is important to monitor blood lipids and administer active treatments in COVID-19 patients with dyslipidemia to reduce the severity and mortality.
Article
Multidisciplinary Sciences
Alhaji H. Janneh et al.
Summary: Changes in sphingolipids are closely related to the development of COVID-19, with reduced levels of sphingosine potentially serving as a sensitive biomarker for the early identification of symptomatic and asymptomatic COVID-19 patients.
SCIENTIFIC REPORTS
(2021)
Article
Biochemistry & Molecular Biology
Nicola Gray et al.
Summary: Using lipid profiling and multivariate modeling, a refined panel of discriminant features from different lipid subclasses was developed to effectively differentiate between SARS-CoV-2 infection, healthy controls, and non-SARS-CoV-2 respiratory infections. The analysis showed strong predictive power and potential for facilitating accurate diagnosis and clinical management of the virus.
Article
Multidisciplinary Sciences
Mehran M. Khodadoust
Summary: The study suggests a causal relationship between plasma ceramide concentration and respiratory distress symptoms in COVID-19 patients, with ceramide class lipids exhibiting a significant increase in infected patients. Specific subclasses of ceramides were shown to be greatly increased in plasma samples with respiratory distress, highlighting the potential value of monitoring plasma ceramide concentration for assessing the effects of therapies on COVID-19 respiratory distress patients.
SCIENTIFIC REPORTS
(2021)
Review
Medicine, General & Internal
Rocio Fuertes-Martin et al.
JOURNAL OF CLINICAL MEDICINE
(2020)
Article
Biochemistry & Molecular Biology
Bo Shen et al.
Review
Cardiac & Cardiovascular Systems
Sevim Zaim et al.
CURRENT PROBLEMS IN CARDIOLOGY
(2020)
Review
Biochemistry & Molecular Biology
Francesca Coperchini et al.
CYTOKINE & GROWTH FACTOR REVIEWS
(2020)
Article
Medicine, General & Internal
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2020)
Article
Oncology
Chao-Wei Lee et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY
(2020)
Review
Cell Biology
Tahmineh Mokhtari et al.
JOURNAL OF MOLECULAR HISTOLOGY
(2020)
Article
Biochemical Research Methods
Torben Kimhofer et al.
JOURNAL OF PROTEOME RESEARCH
(2020)
Article
Biochemistry & Molecular Biology
Guyi Wang et al.
LIPIDS IN HEALTH AND DISEASE
(2020)
Article
Multidisciplinary Sciences
Chiara Bruzzone et al.
Article
Biochemistry & Molecular Biology
Elettra Barberis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2020)
Review
Cardiac & Cardiovascular Systems
Nehal N. Mehta et al.
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY
(2020)
Review
Chemistry, Multidisciplinary
Alessia Vignoli et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
(2019)
Review
Medicine, Research & Experimental
Margery A. Connelly et al.
JOURNAL OF TRANSLATIONAL MEDICINE
(2017)
Review
Biochemistry & Molecular Biology
Kenneth R. Feingold et al.
CURRENT OPINION IN LIPIDOLOGY
(2016)
Article
Multidisciplinary Sciences
Eke G. Gruppen et al.
Review
Cardiac & Cardiovascular Systems
Janna A. van Diepen et al.
Review
Pharmacology & Pharmacy
Gunther Marsche et al.
PHARMACOLOGY & THERAPEUTICS
(2013)
Article
Chemistry, Analytical
Anthony D. Maher et al.
ANALYTICAL CHEMISTRY
(2008)
Article
Chemistry, Analytical
Susanne Wiklund et al.
ANALYTICAL CHEMISTRY
(2008)
